A Preliminary Evaluation of Uptake in Bone Metastases, Biodistribution and Excretion of the Novel Radiotracer [68Ga]P15-041 by PET/CT
Phase of Trial: Phase 0
Latest Information Update: 08 Aug 2017
At a glance
- Drugs P15-041 (Primary)
- Indications Bone metastases
- Focus Pharmacokinetics
- Sponsors Five Eleven Pharma
- 03 Aug 2017 Planned End Date changed from 1 Aug 2017 to 1 Mar 2018.
- 03 Aug 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Sep 2017.
- 25 Jul 2016 Status changed from not yet recruiting to recruiting.